These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14508878)

  • 1. Gram-positive bacterial resistance: future treatment options.
    Bassetti M; Melica G; Di Biagio A; Rosso R; Gatti G; Bassetti D
    Curr Opin Investig Drugs; 2003 Aug; 4(8):944-52. PubMed ID: 14508878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options for Gram-positive infections.
    Rybak MJ
    J Hosp Infect; 2001 Dec; 49 Suppl A():S25-32. PubMed ID: 11926437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.
    Appelbaum PC; Jacobs MR
    Curr Opin Microbiol; 2005 Oct; 8(5):510-7. PubMed ID: 16098786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients.
    Ashour HM; el-Sharif A
    J Clin Oncol; 2007 Dec; 25(36):5763-9. PubMed ID: 18089873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A; Stefanik W
    Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance.
    Segreti J
    Clin Microbiol Infect; 2005 May; 11 Suppl 3():29-35. PubMed ID: 15811022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dalbavancin: a review for dermatologists.
    Scheinfeld N
    Dermatol Online J; 2006 May; 12(4):6. PubMed ID: 17083861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for Gram-positive uropathogens.
    Wagenlehner FM; Naber KG
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S39-43. PubMed ID: 15364305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline: a novel glycylcycline antibiotic.
    Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S; Marchese A; Debbia EA
    Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
    Schweiger ES; Scheinfeld NS; Tischler HR; Weinberg JM
    J Drugs Dermatol; 2003 Aug; 2(4):378-83. PubMed ID: 12884459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
    Pai AB; Pai MP
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.